Facebook-f Instagram Twitter Linkedin-in Youtube

Nextleaf to Launch THC-O as an Excise Tax-Free Alternative to Delta-9-THC (CSE: OILS) (OTCQB: OILFF)

  • June 23, 2022

Nextleaf Solutions Ltd., a federally regulated manufacturer and distributor of cannabis extracts including vapes and oils, is pleased to provide an update on its Specialty Molecules division, specifically the Company’s patented novel route of manufacturing D9-tetrahydrocannabinol acetate (D9-THC-OAc, delta-9-THC-OAc, THC-OAc), colloquially referred to as THC-O (“THC-O”).

Nextleaf has recently produced THC-O under the Company’s Health Canada Research Licence in anticipation of commercialization. Nextleaf has validated its manufacturing process of THC-O through third-party analytical testing.

The Company is of the understanding that THC-O is not subject to excise tax as it does not meet the definition of “Total THC” as defined under the Excise Act 2001, which is aligned with the definition of the same in the Cannabis Act.

In Canada, excise tax of a regulated cannabis extract is based on the amount of total delta-9-THC present. Excise tax is a critical issue in the industry, with some cannabis products manufactured with delta-9-THC subject to excise tax over 40% of the duty paid landed cost to provincial government distributors and medical cannabis distributors.

With THC-O, Nextleaf sees potential for market disruption by marketing its novel cannabinoid ingredient as an excise tax-free alternative to delta-9-THC. Nextleaf intends to commercialize the ingredient as a therapeutic product distributed to provincial distributors and medical cannabis sales partners under the Company’s Health Canada cannabis licences.

Anecdotally, THC-O products have a more gradual onset, are longer-lasting, and have psychedelic-like effects, as compared to delta-9-THC.

“With Nextleaf’s reputation for manufacturing standardized cannabinoid-based ingredients, and distributing Glacial Gold branded products through provincial government distributors, and pharmacies from Coast to Coast, we are excited to lead the way globally on the development of excise tax-free THC-O products manufactured within Health Canada’s regulatory framework,” said Nextleaf Co-Founder and CEO, Paul Pedersen.

Nextleaf’s patented process to manufacture THC-O enables the standardization of a more potent analog of THC. The Company holds U.S. and Canadian patents, along with a U.S. patent for a less efficient method to produce THC-O.

Since the 2018 Farm Bill was passed in the United States, unregulated hemp derived CBD is sold nationwide in the U.S., even in states that have not legalized Delta-9-THC. Because THC-O can be synthesized from hemp, the United States is seeing a surge in popularity for unregulated products marketed as hemp derived THC-O. These products are now being sold alongside the unregulated hemp derived cannabidiol (CBD) products on shelves at gas stations and corner stores throughout the United States.

Nextleaf develops cannabinoid-based vape formulations under its Health Canada Research Licence with sensory evaluation of cannabis via human testing.

CEO Paul Pedersen joined Steve Darling from Proactive to provide more insight: https://www.youtube.com/watch?v=tTp6cyuEemw

About Nextleaf Solutions Ltd.

Nextleaf® is a federally regulated manufacturer and distributor of cannabis vapes and oils under its award-winning prohibition-era brand, Glacial Gold™. The Company’s multi-patented ingredient processing technology transforms cannabis and hemp biomass into high-purity distillate at an industrial scale. Nextleaf is a low-cost producer of cannabis oils, and supplier of THC and CBD ingredients to qualified wholesale partners across Canada. Nextleaf is the first publicly traded company to be issued a U.S. patent for the industrial extraction and purification of cannabinoids. The Company has been issued 18 U.S. patents, and over 95 patents globally, on cannabinoid processing including distillation and acetylation. Nextleaf develops cannabinoid-based formulations and delivery technology through its Health Canada Research Licence with sensory evaluation of cannabis via human testing. For more information visit www.nextleafsolutions.com and www.Glacial.Gold

Nextleaf trades as OILS on the Canadian Securities Exchange, OILFF on the OTCQB Market in the United States, and L0MA on the Frankfurt Stock Exchange.

Follow the Company: Twitter, LinkedIn, Facebook, and Instagram.

Follow Glacial Gold™: Instagram, Twitter, and Facebook.

Jason McBride, Corporate Development
604-283-2301 (ext. 219)
jason@nextleafsolutions.com

Interested in investing in Nextleaf?

Exclusive access to monthly insights from Canada’s most innovative cannabis processor. Join over 7000+ subscribers world-wide!

sign up for updates

The Latest from OILS

Loading...
Cannabis, Chemistry, & Agrology: Why Professional Designations Matter Within The Cannabis Industry

Cannabis, Chemistry, & Agrology: Why Professional Designations Matter Within The Cannabis Industry

Professional designations and accreditation can be a meaningful and valuable way to differentiate the strength of the team behind a brand or company, and their ability to deliver operational excellence and quality.
Read Now
Loading...
THC-

Not All THC Analysis is Created Equal

Canada’s most innovative extraction company, Nextleaf Solutions (CSE: OILS | OTCQB: OILFF | FSE: L0MA) is developing technology for distilling THC and CBD oils used to formulate popular 2.0 products including vape pens, edibles and beverages
Read Now
Loading...
What Does Distillate Cost in Canada?

What Does Distillate Cost In Canada?

There is a combination of fixed and fluctuating factors that affect pricing. This is relevant context for cultivators looking to maximize the value of their harvest, and manufacturers looking to create competitive pricing in their portfolio of cannabis derivative products.
Read Now

Exclusive access to monthly insights from the world’s most innovative cannabis
processor. Join over 7000+ subscribers world-wide.

info@nextleafsolutions.com

  • Privacy
  • Cookie Policy
Menu
  • Privacy
  • Cookie Policy
Linkedin-in Facebook-f Instagram Twitter Youtube
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. Read More
Cookie settingsACCEPT
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT
  • Our Story
    • Team
  • Brands
  • Extraction Tech
    • Rapid Emulsion Tech
  • Services
    • Toll Processing
    • Bulk Sales &
      Purchasing
    • Research &
      Product Development
  • Investor
    • Press Releases
    • Financial Filings
    • Investor Deck
  • Media
    • Insights
    • News
  • Contact
Menu
  • Our Story
    • Team
  • Brands
  • Extraction Tech
    • Rapid Emulsion Tech
  • Services
    • Toll Processing
    • Bulk Sales &
      Purchasing
    • Research &
      Product Development
  • Investor
    • Press Releases
    • Financial Filings
    • Investor Deck
  • Media
    • Insights
    • News
  • Contact
Menu
  • Our Story
    • Team
  • Brands
  • Extraction Tech
    • Rapid Emulsion Tech
  • Services
    • Toll Processing
    • Bulk Sales &
      Purchasing
    • Research &
      Product Development
  • Investor
    • Press Releases
    • Financial Filings
    • Investor Deck
  • Media
    • Insights
    • News
  • Contact
Facebook-f Instagram Twitter Linkedin-in Youtube

SIGN-UP NOW!

Exclusive access to monthly insights from the world’s most innovative cannabis processor. Join over 7000+ subscribers world-wide.
Unsubscribe at any time. Your email will not be shared or distributed. View our privacy policy.

Confirm Your Age

By selecting yes, I certify that I am of legal age in my jurisdiction to consume cannabis.

YES
YES
NO
Remember my answer

INVEST IN THE FUTURE OF CANNABIS

Please enter your email below to receive the Nextleaf Solutions Investor Kit.
Unsubscribe at any time. Your email will not be shared or distributed. View our privacy policy.